To assess the impact of the drugs on T cell phenotypes, we detected the CAR-T cell positive rate (Figure S2C-D) and the CD8+/CD4+ CAR-T cell ratio after co-culture with tumor cells with or without RSL3. The gene discussed is CD8A; the disease is neoplasm.